Cargando…
An Immunophenotyping of Ovarian Cancer With Clinical and Immunological Significance
Immune checkpoint blockade (ICB), mainly anti-CTLA-4 and anti-PD-1/PD-L1 therapy, has showed promising clinical benefits in the treatment of some cancer types; however, its application in ovarian cancer is still in the primary stage. Immunophenotyping can help us understand the clinical characterist...
Autores principales: | Yang, Kai, Zhao, Weiwei, Lou, Ge, Rong, Zhiwei, Xu, Huan, Wang, Wenjie, Song, Wei, Cai, Yuqing, Hou, Yan, Li, Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394551/ https://www.ncbi.nlm.nih.gov/pubmed/32793247 http://dx.doi.org/10.3389/fimmu.2018.00757 |
Ejemplares similares
-
Immunophenotyping of pulmonary sarcomatoid carcinoma
por: Ma, Yu, et al.
Publicado: (2022) -
Prognostic and immunological significance of an M1 macrophage-related gene signature in osteosarcoma
por: Mao, Xiaoyu, et al.
Publicado: (2023) -
Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
por: Yang, Kai, et al.
Publicado: (2017) -
Erratum: Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
por: Yang, Kai, et al.
Publicado: (2017) -
Immunophenotypic studies of monoclonal gammopathy of undetermined significance
por: Olteanu, Horatiu, et al.
Publicado: (2008)